Form 8-K - Current report:
SEC Accession No. 0001558370-23-010276
Filing Date
2023-05-22
Accepted
2023-05-22 08:00:13
Documents
15
Period of Report
2023-05-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tmb-20230517x8k.htm   iXBRL 8-K 84651
2 EX-1.1 tmb-20230517xex1d1.htm EX-1.1 607353
3 EX-99.1 tmb-20230517xex99d1.htm EX-99.1 32414
4 GRAPHIC tmb-20230517xex99d1001.jpg GRAPHIC 8335
  Complete submission text file 0001558370-23-010276.txt   968803

Data Files

Seq Description Document Type Size
5 EX-101.SCH tmb-20230517.xsd EX-101.SCH 3055
6 EX-101.LAB tmb-20230517_lab.xml EX-101.LAB 15357
7 EX-101.PRE tmb-20230517_pre.xml EX-101.PRE 10021
9 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230517x8k_htm.xml XML 4670
Mailing Address 377 PLANTATION STREET WORCESTER MA 01605
Business Address 377 PLANTATION STREET WORCESTER MA 01605 7816524500
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

EIN.: 473828760 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38191 | Film No.: 23942461
SIC: 2834 Pharmaceutical Preparations